MAXI AIDS, INC.

MAXI AIDS, INC. specializes in the manufacturing and supply of specialized medical devices, with a focus on ophthalmic equipment and surgical appliances. Their technical expertise includes the production of precision optical magnifiers and clinical-grade surgical supplies, tailored for institutional healthcare environments. The company demonstrates proficiency in meeting stringent federal specifications for medical device design, materials, and labeling, ensuring compliance with FDA and GSA standards. Their ability to deliver niche, high-accuracy instruments—such as wide-view rectangular magnifiers—suggests a capability in low-volume, high-specification manufacturing, often required for veteran and clinical care settings. The contractor has delivered products to the General Services Administration, the Department of Veterans Affairs, and through the NAC Federal Supply Schedule, indicating consistent engagement with federal procurement channels serving healthcare and veteran services. Work for the VA has involved surgical supply procurement, while GSA contracts have centered on vision-assistive optical devices, suggesting a targeted role in equipping medical and rehabilitative clinics with specialized tools. The recurring presence on the FSS program signals established vendor status within federal supply chains. Industry focus is narrowly defined around NAICS 339115 (ophthalmic goods manufacturing) and 339113 (surgical appliance and supplies manufacturing), positioning MAXI AIDS as a niche supplier in medical instrumentation rather than broad healthcare products. Their market role is that of a precision manufacturer serving institutional buyers who require certified, non-standard clinical devices. As a 2L entity based in Farmingdale, NY, MAXI AIDS operates as a small-scale manufacturer without federal certifications such as 8(a), HUBZone, or WOSB. Their geographic footprint is localized, but their participation in federal supply schedules indicates a strategic alignment with national procurement systems, enabling access to federal healthcare markets despite limited certification status.